What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
Laurent Peyrin-Biroulet spends much of his time researching Internal medicine, Crohn's disease, Ulcerative colitis, Inflammatory bowel disease and Surgery.
His research combines Gastroenterology and Internal medicine.
His Crohn's disease study results in a more complete grasp of Disease.
His Ulcerative colitis course of study focuses on Colitis and Drug resistance.
His research in Inflammatory bowel disease focuses on subjects like Immunology, which are connected to Single-nucleotide polymorphism.
His Surgery research includes themes of Adverse effect, Incidence and Cohort study.
His most cited work include:
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. (1061 citations)
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management (868 citations)
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. (861 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Crohn's disease and Gastroenterology.
In general Internal medicine study, his work on Disease, Infliximab, Adalimumab and Vedolizumab often relates to the realm of In patient, thereby connecting several areas of interest.
His Inflammatory bowel disease research incorporates elements of Odds ratio, Retrospective cohort study, Immunology and Intensive care medicine.
His Ulcerative colitis research integrates issues from Adverse effect, Clinical trial, Colitis and Ustekinumab.
His research in Crohn's disease intersects with topics in Surgery, Cohort study, MEDLINE, Pediatrics and Cohort.
While the research belongs to areas of Gastroenterology, Laurent Peyrin-Biroulet spends his time largely on the problem of Placebo, intersecting his research to questions surrounding Randomized controlled trial.
He most often published in these fields:
- Internal medicine (60.06%)
- Inflammatory bowel disease (41.42%)
- Ulcerative colitis (38.93%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (60.06%)
- Inflammatory bowel disease (41.42%)
- Ulcerative colitis (38.93%)
In recent papers he was focusing on the following fields of study:
Laurent Peyrin-Biroulet mostly deals with Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Crohn's disease and Gastroenterology.
His work on Vedolizumab, Ustekinumab, Infliximab and Adverse effect is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science.
His Inflammatory bowel disease research is multidisciplinary, relying on both Pandemic, Coronavirus disease 2019, MEDLINE and Intensive care medicine.
His studies deal with areas such as Tofacitinib, Colitis and Clinical trial, Randomization as well as Ulcerative colitis.
Crohn's disease is a subfield of Disease that he investigates.
His Gastroenterology study incorporates themes from Inflammation, Faecal calprotectin, Placebo, Biopsy and Endoscopy.
Between 2019 and 2021, his most popular works were:
- Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. (180 citations)
- Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. (94 citations)
- Application of Artificial Intelligence to Gastroenterology and Hepatology (79 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His primary scientific interests are in Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Crohn's disease and Gastroenterology.
His Inflammatory bowel disease research incorporates themes from Pandemic, Coronavirus disease 2019, Intensive care medicine and Outbreak.
His study looks at the relationship between Ulcerative colitis and fields such as Psoriasis, as well as how they intersect with chemical problems.
Disease covers Laurent Peyrin-Biroulet research in Crohn's disease.
When carried out as part of a general Disease research project, his work on Disease burden is frequently linked to work in Clinical Practice, therefore connecting diverse disciplines of study.
His Gastroenterology research integrates issues from Biomarker, Faecal calprotectin, Clinical trial and Biopsy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
